Hippocampal and neocortical BRAF mutant non-expansive lesions in focal epilepsies.
BRAF
CD34
HOPX
epilepsy
hippocampal sclerosis
methylation
senescence
somatic mosaicism
Journal
Neuropathology and applied neurobiology
ISSN: 1365-2990
Titre abrégé: Neuropathol Appl Neurobiol
Pays: England
ID NLM: 7609829
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
revised:
31
08
2023
received:
21
07
2022
accepted:
18
09
2023
medline:
30
10
2023
pubmed:
23
9
2023
entrez:
23
9
2023
Statut:
ppublish
Résumé
Mesial Temporal Lobe Epilepsy-associated Hippocampal Sclerosis (MTLE-HS) is a syndrome associated with various aetiologies. We previously identified CD34-positive extravascular stellate cells (CD34+ cells) possibly related to BRAF We analysed BRAF We identified a BRAF BRAF
Substances chimiques
Proto-Oncogene Proteins B-raf
EC 2.7.11.1
BRAF protein, human
EC 2.7.11.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12937Subventions
Organisme : Assistance Publique-Hôpitaux de Paris
Organisme : Sorbonne Université
Organisme : SiRIC CURAMUS
Organisme : DMU Neuroscience of AP-HP, Sorbonne Université
Organisme : AmourAmourAmour
Organisme : French National Cancer Institute, the French Ministry of Solidarity and Health and Inserm INCA-DGOS-Inserm_12560
Organisme : Fondation pour la Recherche Medicale
ID : FDT202106013286
Informations de copyright
© 2023 The Authors. Neuropathology and Applied Neurobiology published by John Wiley & Sons Ltd on behalf of British Neuropathological Society.
Références
Blumcke I, Spreafico R, Haaker G, et al. Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med. 2017;377(17):1648-1656. doi:10.1056/NEJMoa1703784
Semah F, Picot MC, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 1998;51(5):1256-1262. doi:10.1212/WNL.51.5.1256
Mathon B, Bielle F, Samson S, et al. Predictive factors of long-term outcomes of surgery for mesial temporal lobe epilepsy associated with hippocampal sclerosis. Epilepsia. 2017;58(8):1473-1485. doi:10.1111/epi.13831
Tanriverdi T, Olivier A, Poulin N, Andermann F, Dubeau F. Long-term seizure outcome after mesial temporal lobe epilepsy surgery: corticalamygdalohippocampectomy versus selective amygdalohippocampectomy. J Neurosurg. 2008;108(3):517-524. doi:10.3171/JNS/2008/108/3/0517
Abosch A, Bernasconi N, Boling W, et al. Factors predictive of suboptimal seizure control following selective amygdalohippocampectomy. J Neurosurg. 2002;97(5):1142-1151. doi:10.3171/jns.2002.97.5.1142
Coras R, Pauli E, Li J, et al. Differential influence of hippocampal subfields to memory formation: insights from patients with temporal lobe epilepsy. Brain. 2014;137(7):1945-1957. doi:10.1093/brain/awu100
Hermann BP, Wyler AR, Somes G, Berry AD 3rd, Dohan FC Jr. Pathological status of the mesial temporal lobe predicts memory outcome from left anterior temporal lobectomy. Neurosurgery. 1992;31(4):652-656; discussion 6-7, 657. doi:10.1227/00006123-199210000-00006
Waseem H, Osborn KE, Schoenberg MR, et al. Predictors of surgical outcome in medically-resistant temporal lobe epilepsy with bilateral features on pre-operative evaluation. Clin Neurol Neurosurg. 2015;139:199-205. doi:10.1016/j.clineuro.2015.10.016
Willment KC, Golby A. Hemispheric lateralization interrupted: material-specific memory deficits in temporal lobe epilepsy. Front Hum Neurosci. 2013;7:546.
Janszky J, Janszky I, Schulz R, et al. Temporal lobe epilepsy with hippocampal sclerosis: predictors for long-term surgical outcome. Brain. 2005;128(Pt 2):395-404. doi:10.1093/brain/awh358
Wieser HG, Epilepsy ICoNo. ILAE commission report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia. 2004;45(6):695-714. doi:10.1111/j.0013-9580.2004.09004.x
Goldberg EM, Coulter DA. Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat Rev Neurosci. 2013;14(5):337-349. doi:10.1038/nrn3482
Glover RL, DeNiro LV, Lasala PA, Weidenheim KM, Graber JJ, Boro A. ILAE type 3 hippocampal sclerosis in patients with anti-GAD-related epilepsy. Neurol Neuroimmunol Neuroinflamm. 2015;2(4):e122. doi:10.1212/NXI.0000000000000122
Japp A, Gielen GH, Becker AJ. Recent aspects of classification and epidemiology of epilepsy-associated tumors. Epilepsia. 2013;54(Suppl 9):5-11. doi:10.1111/epi.12436
Abou-Khalil B, Ge Q, Desai R, et al. Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation. Neurology. 2001;57(12):2265-2272. doi:10.1212/WNL.57.12.2265
Scheffer IE, Harkin LA, Grinton BE, et al. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations. Brain. 2007;130(Pt 1):100-109. doi:10.1093/brain/awl272
Calderon-Garciduenas AL, Mathon B, Levy P, et al. New clinicopathological associations and histoprognostic markers in ILAE types of hippocampal sclerosis. Brain Pathol. 2018;28(5):644-655. doi:10.1111/bpa.12596
Blumcke I, Giencke K, Wardelmann E, et al. The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies. Acta Neuropathol. 1999;97(5):481-490. doi:10.1007/s004010051017
Huse JT, Edgar M, Halliday J, Mikolaenko I, Lavi E, Rosenblum MK. Multinodular and vacuolating neuronal tumors of the cerebrum: 10 cases of a distinctive seizure-associated lesion. Brain Pathol. 2013;23(5):515-524. doi:10.1111/bpa.12035
Huse JT, Snuderl M, Jones DT, et al. Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathol. 2017;133(3):417-429. doi:10.1007/s00401-016-1639-9
Ida CM, Johnson DR, Nair AA, et al. Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): molecular profiling confirms frequent MAPK pathway activation. J Neuropathol Exp Neurol. 2021;80(9):821-829. doi:10.1093/jnen/nlab075
Pasquier B, Peoc HM, Fabre-Bocquentin B, et al. Surgical pathology of drug-resistant partial epilepsy. A 10-year-experience with a series of 327 consecutive resections. Epileptic Disord. 2002;4(2):99-119.
Pekmezci M, Stevers M, Phillips JJ, et al. Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway. Acta Neuropathol. 2018;135(3):485-488. doi:10.1007/s00401-018-1820-4
WHO. Central Nervous System Tumours. 5thed. International Agency for Research On Cancer; 2021.
Surrey LF, Jain P, Zhang B, et al. Genomic analysis of dysembryoplastic neuroepithelial tumor spectrum reveals a diversity of molecular alterations dysregulating the MAPK and PI3K/mTOR pathways. J Neuropathol Exp Neurol. 2019;78(12):1100-1111. doi:10.1093/jnen/nlz101
Prabowo AS, Iyer AM, Veersema TJ, et al. BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors. Brain Pathol. 2014;24(1):52-66. doi:10.1111/bpa.12081
Blümcke I, Wiestler OD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol. 2002;61(7):575-584. doi:10.1093/jnen/61.7.575
Deb P, Sharma MC, Tripathi M, Sarat Chandra P, Gupta A, Sarkar C. Expression of CD34 as a novel marker for glioneuronal lesions associated with chronic intractable epilepsy. Neuropathol Appl Neurobiol. 2006;32(5):461-468. doi:10.1111/j.1365-2990.2006.00734.x
Fauser S, Becker A, Schulze-Bonhage A, et al. CD34-immunoreactive balloon cells in cortical malformations. Acta Neuropathol. 2004;108(4):272-278. doi:10.1007/s00401-004-0889-0
Marucci G, Martinoni M, Giulioni M. Relationship between focal cortical dysplasia and epilepsy-associated low-grade tumors: an immunohistochemical study. APMIS. 2013;121(1):22-29. doi:10.1111/j.1600-0463.2012.02938.x
Thom M, Toma A, An S, et al. One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature. J Neuropathol Exp Neurol. 2011;70(10):859-878. doi:10.1097/NEN.0b013e3182302475
Lin G, Finger E, Gutierrez-Ramos JC. Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues. Eur J Immunol. 1995;25(6):1508-1516. doi:10.1002/eji.1830250606
Schindler G, Capper D, Meyer J, et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol. 2011;121(3):397-405. doi:10.1007/s00401-011-0802-6
Marucci G, de Biase D, Visani M, et al. Mutant BRAF in low-grade epilepsy-associated tumors and focal cortical dysplasia. Ann Clin Transl Neurol. 2014;1(2):130-134. doi:10.1002/acn3.31
Khoshkhoo S, Wang Y, Chahine Y, et al. Contribution of somatic ras/raf/mitogen-activated protein kinase variants in the hippocampus in drug-resistant mesial temporal lobe epilepsy. JAMA Neurol. 2023;80(6):578-587. doi:10.1001/jamaneurol.2023.0473
Sim NS, Ko A, Kim WK, et al. Precise detection of low-level somatic mutation in resected epilepsy brain tissue. Acta Neuropathol. 2019;138(6):901-912. doi:10.1007/s00401-019-02052-6
Blumcke I, Thom M, Aronica E, et al. International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a task force report from the ILAE commission on diagnostic methods. Epilepsia. 2013;54(7):1315-1329. doi:10.1111/epi.12220
Capper D, Jones DTW, Sill M, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469-474. doi:10.1038/nature26000
Wu Z, Lopes Abath Neto O, Bale TA, et al. DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival. Acta Neuropathol. 2022;144(1):155-157. doi:10.1007/s00401-022-02430-7
Aryee MJ, Jaffe AE, Corrada-Bravo H, et al. Minfi: a flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363-1369. doi:10.1093/bioinformatics/btu049
Fortin JP, Triche TJ Jr, Hansen KD. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2017;33(4):558-560. doi:10.1093/bioinformatics/btw691
Triche TJ Jr, Weisenberger DJ, Van Den Berg D, Laird PW, Siegmund KD. Low-level processing of Illumina Infinium DNA methylation BeadArrays. Nucleic Acids Res. 2013;41(7):e90. doi:10.1093/nar/gkt090
Benton MC, Johnstone A, Eccles D, et al. An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss. Genome Biol. 2015;16(1):8. doi:10.1186/s13059-014-0569-x
Chen YA, Lemire M, Choufani S, et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics. 2013;8(2):203-209. doi:10.4161/epi.23470
McCartney DL, Walker RM, Morris SW, McIntosh AM, Porteous DJ, Evans KL. Identification of polymorphic and off-target probe binding sites on the Illumina Infinium MethylationEPIC BeadChip. Genom Data. 2016;9:22-24. doi:10.1016/j.gdata.2016.05.012
Pidsley R, Zotenko E, Peters TJ, et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 2016;17(1):208. doi:10.1186/s13059-016-1066-1
Stuart T, Butler A, Hoffman P, et al. Comprehensive integration of single-cell data. Cell. 2019;177:1888-1902.e21. doi:10.1016/j.cell.2019.05.031
Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S a. 2005;102(43):15545-15550. doi:10.1073/pnas.0506580102
Wolf FA, Angerer P, Theis FJ. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 2018;19(1):15. doi:10.1186/s13059-017-1382-0
Bhaduri A, Di Lullo E, Jung D, et al. Outer radial glia-like cancer stem cells contribute to heterogeneity of glioblastoma. Cell Stem Cell. 2020;26:48-63.e6. doi:10.1016/j.stem.2019.11.015
Bielle F, Ducray F, Mokhtari K, et al. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co-deleted anaplastic gliomas. Brain Pathol. 2017;27(5):567-579. doi:10.1111/bpa.12434
Bernauer TA. The radial bands sign. Radiology. 1999;212(3):761-762. doi:10.1148/radiology.212.3.r99se17761
Fridman AL, Tainsky MA. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene. 2008;27(46):5975-5987. doi:10.1038/onc.2008.213
Sun T, Hevner RF. Growth and folding of the mammalian cerebral cortex: from molecules to malformations. Nat Rev Neurosci. 2014;15(4):217-232. doi:10.1038/nrn3707
D'Gama AM, Walsh CA. Somatic mosaicism and neurodevelopmental disease. Nat Neurosci. 2018;21(11):1504-1514. doi:10.1038/s41593-018-0257-3
Watanabe Y, Shido K, Niihori T, et al. Somatic BRAF c.1799T>A p.V600E Mosaicism syndrome characterized by a linear syringocystadenoma papilliferum, anaplastic astrocytoma, and ocular abnormalities. Am J Med Genet a. 2016;170A(1):189-194. doi:10.1002/ajmg.a.37376
Severino M, Geraldo AF, Utz N, et al. Definitions and classification of malformations of cortical development: practical guidelines. Brain. 2020;143(10):2874-2894. doi:10.1093/brain/awaa174
Koh HY, Kim SH, Jang J, et al. BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors. Nat Med. 2018;24(11):1662-1668. doi:10.1038/s41591-018-0172-x
Cases-Cunillera S, van Loo KMJ, Pitsch J, et al. Heterogeneity and excitability of BRAFV600E-induced tumors is determined by Akt/mTOR-signaling state and Trp53-loss. Neuro Oncol. 2022;24(5):741-754. doi:10.1093/neuonc/noab268
Carreno G, Guiho R, Martinez-Barbera JP. Cell senescence in neuropathology: a focus on neurodegeneration and tumours. Neuropathol Appl Neurobiol. 2021;47(3):359-378. doi:10.1111/nan.12689
Gorgoulis V, Adams PD, Alimonti A, et al. Cellular senescence: defining a path forward. Cell. 2019;179(4):813-827. doi:10.1016/j.cell.2019.10.005
Milanovic M, Fan DNY, Belenki D, et al. Senescence-associated reprogramming promotes cancer stemness. Nature. 2018;553(7686):96-100. doi:10.1038/nature25167
Kim S, Baldassari S, Sim NS, et al. Detection of brain somatic mutations in cerebrospinal fluid from refractory epilepsy patients. Ann Neurol. 2021;89(6):1248-1252. doi:10.1002/ana.26080
Zhang P, Kishimoto Y, Grammatikakis I, et al. Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model. Nat Neurosci. 2019;22(5):719-728. doi:10.1038/s41593-019-0372-9